世界肝炎日：通过合作在格鲁吉亚消灭肝炎病(World Health Organization)

病毒性肝炎影响到全球4亿多人，比携带艾滋病病毒的人数多10倍以上。但是有许多人完全不知自己患病。

7月28日是世界肝炎日（World Hepatitis Day）。组织者制定出远大目标，到2030年使肝炎不再是公共健康威胁。

病毒性肝炎分为五种类型，即甲型、乙型、丙型、丁型和戊型。每一种肝炎都可能有相似的症状，但是它们的传播方式不同，对肝脏的影响也不同。

目前，专家正在注视格鲁吉亚的一个首创项目。它是2015年以来在政府、制药公司和普通老百姓之间开展的一项消灭肝炎的通力合作。（格鲁吉亚是世界上肝炎最高发地区之一。）

格鲁吉亚政府与美国疾病控制与预防中心（U.S. Centers for Disease Control and Prevention） 合作，将检验和其他预防措施从首都扩大到全国的17个地点。与此同时，肝炎高效药制造商吉利德科学公司（Gilead Sciences）免费向格鲁吉亚公民提供药品。

格鲁吉亚传染病、临床免疫和艾滋病研究中心（Infectious Diseases, Clinical Immunology and AIDS Research Center）负责人田吉兹·车茨瓦泽（Tengiz Tsertsvadze）表示，迄今取得的结果非常可观，在参加治疗的将近9000人中，“大约83%……治愈”。

世界肝炎联盟（World Hepatitis Alliance）认为，类似在格鲁吉亚进行的战略性努力有可能在14年里挽救大约710万人。

关注#WorldHepDay世界肝炎日和#NOhep消灭肝炎运动；通过世界卫生组织（World Health Organization）更多了解全球消灭肝炎的努力。。

On #WorldHepDay: Partnership seeks to eradicate hepatitis in Georgia

https://share.america.gov/wp-content/uploads/2016/07/WorldHepEng.jpg

Viral hepatitis affects more than 400 million people around the world, more than 10 times the number of people affected by HIV. Yet people with this dangerous liver-attacking disease rarely know they have it.

July 28 is World Hepatitis Day. Organizers have set out an ambitious goal to eliminate hepatitis as a public health threat by 2030.

Viral hepatitis is inflammation of the liver caused by a virus. There are five different hepatitis viruses — hepatitis A, B, C, D and E. Each can cause similar symptoms, but they have different modes of transmission and can affect the liver differently.

Experts are watching a first-of-its-kind program in Georgia, where a team of governments, drug companies and ordinary people have been working to eliminate the disease since 2015. (Georgia has one of the highest rates of hepatitis in the world.)

Working with the U.S. Centers for Disease Control and Prevention, the government of Georgia has expanded screening and other prevention efforts from the capital to 17 sites around the country. At the same time, Gilead Sciences, maker of highly effective hepatitis drugs, has offered to provide medicines at no cost to citizens of Georgia.

So far, results are impressive, according to Tengiz Tsertsvadze, the head of Georgia’s Infectious Diseases, Clinical Immunology and AIDS Research Center. Of almost 9,000 people who have entered treatment, “about 83 percent … were cured,” he said.

The World Hepatitis Alliance says strategic efforts like the one in Georgia could save an estimated 7.1 million people in 14 years.

Follow #WorldHepDay and the #NOhep campaign, and find out more about global eradication efforts from the World Health Organization.